Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, top-performing sectors, and what’s next for biotech investors.

Dubai’s physical real estate market is showing resilience, with transaction volumes rebounding sharply the second week of March, even as listed property stocks continue to reprice risk ...

Shenouda With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, ...

Williams-Sonoma, Inc. (NYSE:WSM) Q4 2025 Earnings Call Transcript March 18, 2026 Williams-Sonoma, Inc. beats earnings expectations. Reported EPS is $3.04, expectations were $2.9. Operator: Welcome to ...

Solo Brands, Inc. (NYSE: SBDS) (“Solo Brands” or “the Company”), a leading portfolio of lifestyle brands (Solo Stove, Chubbies, ISLE and Oru) that are redefining the outdoor and apparel industries, ...

For the quarter ended December 31, 2025, Calamos Growth Fund returned 1.75% (Class I shares at NAV) versus the S&P 1500 Growth Index return of 2.12%. Read more here.

The Board of Fidelity European Trust PLC (the “Company”) recommends a final dividend of 6.00 pence which together with the interim dividend payment of 3.90 pence per share (totalling 9.90 pence) ...

Boeing’s commercial airplane division will likely post an operating margin loss of 7.5 per cent to 8 per cent in the first quarter ...

In patients who had progressed on one prior ARPI, FG3246 plus enzalutamide yielded a median radiographic progression-free survival (rPFS) of 10.1 months and PSA50 response of 40%. Phase I Monotherapy ...

The PGIM Jennison Energy Infrastructure Fund outperformed its benchmark in 4Q25 due to AI-driven gas demand. Read the full ...